Plasma Fractionation Market to Reach USD 51.83 Billion by 2028

Posted by saurabh on May 24th, 2022

The global plasma fractionation market size is expected to showcase significant growth by reaching USD 51.83 billion by 2028. This information is published in a report by Fortune Business Insights, titled “Plasma Fractionation Market, 2021-2028.” The report further mentions that the market stood at USD 29.10 billion in 2020 and is likely to exhibit a CAGR of 6.9% between 2021 and 2028. This is attributable to the factors such as the increasing adoption of immunoglobulin and the growing focus on introducing advanced treatment solutions is expected to boost the demand for the product worldwide.

Get Sample PDF Brochure:

https://www.fortunebusinessinsights.com/enquiry/sample/plasma-fractionation-market-101614

Competitive Landscape:

An exhaustive company profile, along with the data regarding the production graph, product offerings, and revenue accounted for by each company is entailed within the report.

Additionally, it outlines the pricing trends followed and the gross margins recorded by each manufacturer, along with the share of the market held by them over the forecast period.

Objectives of the Study:

To provide a complete analysis of the global market by material type, by age group, by end user, and by region
Provide extensive information on factors affecting market growth (drivers, opportunities, restraints, and industry-specific restraints)
Forecasting and evaluating micro-markets and overall markets
To estimate market sizes in Latin America, North America, Europe, Asia Pacific, and the Middle East & Africa
Analyzing and evaluating competitive landscapes- new product launches, expansions and mergers

Some of the key points covered in the report are:

Analysis of competitors
What\'s Next
Market Data Forecast
Opportunity and Risks Assessment
Market Dynamics and Trends

Industry Development:

• March 2020 – Houston Methodist Hospital became the first-ever hospital to try blood transfusion therapy with the help of a patient recovered from the COVID-19. The individual donated his blood plasma for the transfusion termed as convalescent serum therapy.

To get to know more about the short-term and long-term impacts of COVID-19 on this market Please visit:https://www.fortunebusinessinsights.com/industry-reports/plasma-fractionation-market-101614